NanoPass Technologies, a Ness Ziona, Israel-based provider of intradermal delivery solutions, raised $6M in funding.
The round was led by Awz Ventures, which provided $4M.
The company intends to use the funds to expand its commercial reach.
Led by new CEO Daniel Levitats, NanoPass is an innovator in intradermal delivery technology, specializing in developing solutions for efficient therapeutic and medical aesthetic treatments. The company’s MicronJet™ product platform enables product delivery, offering precision, consistency, and safety that surpasses any traditional injection methods. The MicronJet™ solution platform leverages (MEMS) Micro Electro Mechanical Systems technology, meticulously designed to optimize product delivery performance, setting a new standard in both challenging and commonly performed therapeutic and aesthetic procedures. The key features of the MicronJet™ platform include a proprietary pure silicon crystal-made hollow pyramid structure.
Commenting on the news, Daniel Levitats said: “We are thrilled to have Awz Ventures onboard as a strategic investor and are excited to continue our journey of innovation and growth in the intradermal delivery space.”
FinSMEs
15/07/2024